Holmusk closes US$21.5M Series A to build real-world evidence platform for mental health

Holmusk, a data science and healthtech company headquartered in Singapore, announced today it has closed a US$21.5 million funding round, led by US-based Optum Ventures (OV) and Health Catalyst Capital (HCC). Existing investor Singapore-based Heritas Capital and other unnamed individuals also joined the round. The new funding round allows Holmusk to expand its US operations […] The post Holmusk closes US$21.5M Series A to build real-world evidence platform for mental health appeared first on e27.